MedPath
HSA Approval

SWAMLO TABLETS 10MG

SIN14187P

SWAMLO TABLETS 10MG

SWAMLO TABLETS 10MG

July 4, 2012

ZIWELL MEDICAL (S) PTE LTD

ZIWELL MEDICAL (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZIWELL MEDICAL (S) PTE LTD
Licence HolderZIWELL MEDICAL (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C08CA01

amlodipine

Manufacturer Information

ZIWELL MEDICAL (S) PTE LTD

Ind-Swift Limited

Active Ingredients

Amlodipine Besilate 13.9mg eqv to Amlodipine 10mg

10MG

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SWAMLO TABLETS 10MG - HSA Approval | MedPath